Abstract
Research showing that microRNAs (miRNAs) are versatile regulators of gene expression has instigated tremendous interest in cardiovascular research. The overwhelming majority of studies are predicated on the dogmatic notion that miRNAs regulate the expression of specific target mRNAs by inhibiting mRNA translation or promoting mRNA decay in the RNA-induced silencing complex (RISC). These efforts mostly identified and dissected contributions of multiple regulatory networks of miRNA–target mRNAs to cardiovascular pathogenesis. However, evidence from studies in the past decade indicates that miRNAs also operate beyond this canonical paradigm, featuring non-conventional regulatory functions and cellular localizations that have a pathophysiological role in cardiovascular disease. In this Review, we highlight the functional relevance of atypical miRNA biogenesis and localization as well as RISC heterogeneity. Moreover, we delineate remarkable non-canonical examples of miRNA functionality, including direct interactions with proteins beyond the Argonaute family and their role in transcriptional regulation in the nucleus and in mitochondria. We scrutinize the relevance of non-conventional biogenesis and non-canonical functions of miRNAs in cardiovascular homeostasis and pathology, and contextualize how uncovering these non-conventional properties can expand the scope of translational research in the cardiovascular field and beyond.
Key points
-
MicroRNAs (miRNAs) are non-coding RNAs that mediate post-transcriptional repression of gene expression by pairing and loading target transcripts in RNA-induced silencing complexes, profoundly regulating cardiovascular development, physiology and disease progression.
-
The canonical biogenesis of miRNAs, involving transcription of canonical miRNA genes and two cleavage steps by the microprocessor complex and Dicer, can be bypassed by certain miRNAs that have relevant cardiovascular effects.
-
Non-canonical biogenesis involves alternative sources of precursors, miRNA duplexes with double functional strands for synergistic effects, miRNA isoforms with distinct targeting specificity after ischaemia, or even translation into small peptides.
-
In addition to RNA-induced silencing in the cytoplasm, miRNAs affect gene expression by regulating transcription and the epigenetic status of gene promoters and enhancers in the nucleus, and by targeting mitochondrially encoded transcripts.
-
miRNAs can directly affect protein functions by direct biophysical interactions, ultimately modulating crucial aspects of cardiovascular biology, such as endothelial integrity (miR-126-5p by inhibiting caspase 3) or cardiac action potential (miR-1-3p by binding to Kir2.1).
-
Extracellular miRNAs can mediate intercellular communication by silencing targets or interacting with cellular receptors, such as Toll-like receptors, in recipient cells, and the levels of extracellular miRNAs can be altered in cardiovascular diseases.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Change history
30 May 2022
A Correction to this paper has been published: https://doi.org/10.1038/s41569-022-00733-6
References
Bartel, D. P. Metazoan microRNAs. Cell 173, 20–51 (2018).
Meister, G. et al. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol. Cell 15, 185–197 (2004).
Park, M. S. et al. Human Argonaute3 has slicer activity. Nucleic Acids Res. 45, 11867–11877 (2017).
Shin, C. et al. Expanding the microRNA targeting code: functional sites with centered pairing. Mol. Cell 38, 789–802 (2010).
Hansen, T. B. et al. miRNA-dependent gene silencing involving Ago2-mediated cleavage of a circular antisense RNA. EMBO J. 30, 4414–4422 (2011).
Gebert, L. F. R. & MacRae, I. J. Regulation of microRNA function in animals. Nat. Rev. Mol. Cell Biol. 20, 21–37 (2019).
Yang, W. J. et al. Dicer is required for embryonic angiogenesis during mouse development. J. Biol. Chem. 280, 9330–9335 (2005).
da Costa Martins, P. A. et al. Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling. Circulation 118, 1567–1576 (2008).
Hartmann, P. et al. Endothelial Dicer promotes atherosclerosis and vascular inflammation by miRNA-103-mediated suppression of KLF4. Nat. Commun. 7, 10521 (2016).
Zahedi, F. et al. Dicer generates a regulatory microRNA network in smooth muscle cells that limits neointima formation during vascular repair. Cell Mol. Life Sci. 74, 359–372 (2017).
La Rocca, G. et al. Inducible and reversible inhibition of miRNA-mediated gene repression in vivo. eLife 10, e70948 (2021).
Taubel, J. et al. Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human phase 1b randomized, double-blind, placebo-controlled study. Eur. Heart J. 42, 178–188 (2021).
Abplanalp, W. T. et al. Efficiency and target derepression of anti-miR-92a: results of a first in human study. Nucleic Acid. Ther. 30, 335–345 (2020).
Barwari, T., Joshi, A. & Mayr, M. MicroRNAs in cardiovascular disease. J. Am. Coll. Cardiol. 68, 2577–2584 (2016).
Thum, T. & Condorelli, G. Long noncoding RNAs and microRNAs in cardiovascular pathophysiology. Circ. Res. 116, 751–762 (2015).
Peters, L. J. F. et al. Small things matter: relevance of microRNAs in cardiovascular disease. Front. Physiol. 11, 793 (2020).
Boon, R. A. & Dimmeler, S. MicroRNAs in myocardial infarction. Nat. Rev. Cardiol. 12, 135–142 (2015).
Schober, A., Nazari-Jahantigh, M. & Weber, C. MicroRNA-mediated mechanisms of the cellular stress response in atherosclerosis. Nat. Rev. Cardiol. 12, 361–374 (2015).
Ruby, J. G., Jan, C. H. & Bartel, D. P. Intronic microRNA precursors that bypass Drosha processing. Nature 448, 83–86 (2007).
Cheloufi, S., Dos Santos, C. O., Chong, M. M. & Hannon, G. J. A dicer-independent miRNA biogenesis pathway that requires Ago catalysis. Nature 465, 584–589 (2010).
Lee, Y. S., Shibata, Y., Malhotra, A. & Dutta, A. A novel class of small RNAs: tRNA-derived RNA fragments (tRFs). Genes Dev. 23, 2639–2649 (2009).
Ender, C. et al. A human snoRNA with microRNA-like functions. Mol. Cell 32, 519–528 (2008).
Babiarz, J. E., Ruby, J. G., Wang, Y., Bartel, D. P. & Blelloch, R. Mouse ES cells express endogenous shRNAs, siRNAs, and other microprocessor-independent, Dicer-dependent small RNAs. Genes Dev. 22, 2773–2785 (2008).
Zamudio, J. R., Kelly, T. J. & Sharp, P. A. Argonaute-bound small RNAs from promoter-proximal RNA polymerase II. Cell 156, 920–934 (2014).
Ribeiro Da Fonseca, B. H., Domingues, D. S. & Paschoal, A. R. mirtronDB: a mirtron knowledge base. Bioinformatics 35, 3873–3874 (2019).
Bortolamiol-Becet, D. et al. Selective suppression of the splicing-mediated microRNA pathway by the terminal uridyltransferase tailor. Mol. Cell 59, 217–228 (2015).
Ren, X. P. et al. MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation 119, 2357–2366 (2009).
Li, F. et al. miR-320 accelerates chronic heart failure with cardiac fibrosis through activation of the IL6/STAT3 axis. Aging 13, 22516–22527 (2021).
Hu, H. et al. Knockdown of lncRNA MALAT1 attenuates acute myocardial infarction through miR-320-Pten axis. Biomed. Pharmacother. 106, 738–746 (2018).
Tian, Z. Q., Jiang, H. & Lu, Z. B. MiR-320 regulates cardiomyocyte apoptosis induced by ischemia-reperfusion injury by targeting AKIP1. Cell Mol. Biol. Lett. 23, 41 (2018).
Chen, C. et al. Differentially expressed lnc-NOS2P3-miR-939-5p axis in chronic heart failure inhibits myocardial and endothelial cells apoptosis via iNOS/TNFα pathway. J. Cell Mol. Med. 24, 11381–11396 (2020).
Jones, D. et al. Mirtron microRNA-1236 inhibits VEGFR-3 signaling during inflammatory lymphangiogenesis. Arterioscler. Thromb. Vasc. Biol. 32, 633–642 (2012).
Cifuentes, D. et al. A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity. Science 328, 1694–1698 (2010).
Yoda, M. et al. Poly(A)-specific ribonuclease mediates 3′-end trimming of Argonaute2-cleaved precursor microRNAs. Cell Rep. 5, 715–726 (2013).
Patrick, D. M. et al. Defective erythroid differentiation in miR-451 mutant mice mediated by 14-3-3ζ. Genes Dev. 24, 1614–1619 (2010).
Zhang, X. et al. Synergistic effects of the GATA-4-mediated miR-144/451 cluster in protection against simulated ischemia/reperfusion-induced cardiomyocyte death. J. Mol. Cell Cardiol. 49, 841–850 (2010).
Kuwabara, Y. et al. MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1/AMPK pathway. Circ. Res. 116, 279–288 (2015).
Liang, C. et al. MiR-451 antagonist protects against cardiac fibrosis in streptozotocin-induced diabetic mouse heart. Life Sci. 224, 12–22 (2019).
Wang, X. et al. Loss of the miR-144/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1. Cardiovasc. Res. 94, 379–390 (2012).
Chen, L. J. et al. MicroRNA mediation of endothelial inflammatory response to smooth muscle cells and its inhibition by atheroprotective shear stress. Circ. Res. 116, 1157–1169 (2015).
Chen, L. J., Chuang, L., Huang, Y. H., Chien, S. & Chiu, J. J. MicroRNA-451 protects against atherosclerotic plaque formation by directly targeting Ras-associated protein 5a in vascular smooth muscle cells. FASEB J. 29, 1047.2 (2015).
Hamid, S. M. et al. Inositol-requiring enzyme-1 regulates phosphoinositide signaling lipids and macrophage growth. EMBO Rep. 21, e51462 (2020).
Tufanli, O. et al. Targeting IRE1 with small molecules counteracts progression of atherosclerosis. Proc. Natl Acad. Sci. USA 114, E1395–E1404 (2017).
Fish, J. E. et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev. Cell 15, 272–284 (2008).
Wang, S. et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev. Cell 15, 261–271 (2008).
Moreau, P. R. et al. Profiling of primary and mature miRNA expression in atherosclerosis-associated cell types. Arterioscler. Thromb. Vasc. Biol. 41, 2149–2167 (2021).
Harris, T. A., Yamakuchi, M., Ferlito, M., Mendell, J. T. & Lowenstein, C. J. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc. Natl Acad. Sci. USA 105, 1516–1521 (2008).
Zernecke, A. et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci. Signal. 2, ra81 (2009).
Guo, F. H. et al. Single-cell transcriptome analysis reveals embryonic endothelial heterogeneity at spatiotemporal level and multifunctions of microRNA-126 in mice. Arterioscler. Thromb. Vasc. Biol. 42, 326–342 (2022).
Schober, A. et al. MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat. Med. 20, 368–376 (2014).
Santovito, D. et al. Noncanonical inhibition of caspase-3 by a nuclear microRNA confers endothelial protection by autophagy in atherosclerosis. Sci. Transl Med. 12, eaaz2294 (2020).
Guixe-Muntet, S. et al. Cross-talk between autophagy and KLF2 determines endothelial cell phenotype and microvascular function in acute liver injury. J. Hepatol. 66, 86–94 (2017).
Hsieh, P. N. et al. A conserved KLF-autophagy pathway modulates nematode lifespan and mammalian age-associated vascular dysfunction. Nat. Commun. 8, 914 (2017).
Sangwung, P. et al. KLF2 and KLF4 control endothelial identity and vascular integrity. JCI Insight 2, e91700 (2017).
Wu, W. et al. Flow-dependent regulation of Kruppel-like factor 2 is mediated by microRNA-92a. Circulation 124, 633–641 (2011).
Leidal, A. M. et al. The LC3-conjugation machinery specifies the loading of RNA-binding proteins into extracellular vesicles. Nat. Cell Biol. 22, 187–199 (2020).
Liao, C. C., Ho, M. Y., Liang, S. M. & Liang, C. M. Autophagic degradation of SQSTM1 inhibits ovarian cancer motility by decreasing DICER1 and AGO2 to induce MIRLET7A-3P. Autophagy 14, 2065–2082 (2018).
Schober, A. et al. MicroRNA-21 controls circadian regulation of apoptosis in atherosclerotic lesions. Circulation 144, 1059–1073 (2021).
Thum, T. et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456, 980–984 (2008).
Liang, H. et al. A novel reciprocal loop between microRNA-21 and TGFβRIII is involved in cardiac fibrosis. Int. J. Biochem. Cell Biol. 44, 2152–2160 (2012).
Yuan, J. et al. Mir-21 promotes cardiac fibrosis after myocardial infarction via targeting Smad7. Cell Physiol. Biochem. 42, 2207–2219 (2017).
Zhou, X. L. et al. miR-21 promotes cardiac fibroblast-to-myofibroblast transformation and myocardial fibrosis by targeting Jagged1. J. Cell Mol. Med. 22, 3816–3824 (2018).
Roy, S. et al. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc. Res. 82, 21–29 (2009).
Bang, C. et al. Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J. Clin. Invest. 124, 2136–2146 (2014).
Yan, M. et al. miR-21-3p regulates cardiac hypertrophic response by targeting histone deacetylase-8. Cardiovasc. Res. 105, 340–352 (2015).
Lorenzen, J. M. et al. Osteopontin is indispensible for AP1-mediated angiotensin II-related miR-21 transcription during cardiac fibrosis. Eur. Heart J. 36, 2184–2196 (2015).
Ohanian, M., Humphreys, D. T., Anderson, E., Preiss, T. & Fatkin, D. A heterozygous variant in the human cardiac miR-133 gene, MIR133A2, alters miRNA duplex processing and strand abundance. BMC Genet. 14, 18 (2013).
Telonis, A. G., Loher, P., Jing, Y., Londin, E. & Rigoutsos, I. Beyond the one-locus-one-miRNA paradigm: microRNA isoforms enable deeper insights into breast cancer heterogeneity. Nucleic Acids Res. 43, 9158–9175 (2015).
Guo, L. & Chen, F. A challenge for miRNA: multiple isomiRs in miRNAomics. Gene 544, 1–7 (2014).
Guo, L. et al. Consistent isomiR expression patterns and 3′ addition events in miRNA gene clusters and families implicate functional and evolutionary relationships. Mol. Biol. Rep. 39, 6699–6706 (2012).
Chiang, H. R. et al. Mammalian microRNAs: experimental evaluation of novel and previously annotated genes. Genes Dev. 24, 992–1009 (2010).
Tan, G. C. et al. 5′ isomiR variation is of functional and evolutionary importance. Nucleic Acids Res. 42, 9424–9435 (2014).
Sheu-Gruttadauria, J., Xiao, Y., Gebert, L. F. & MacRae, I. J. Beyond the seed: structural basis for supplementary microRNA targeting by human Argonaute2. EMBO J. 38, e101153 (2019).
Fernandez-Valverde, S. L., Taft, R. J. & Mattick, J. S. Dynamic isomiR regulation in Drosophila development. RNA 16, 1881–1888 (2010).
van der Kwast, R., Woudenberg, T., Quax, P. H. A. & Nossent, A. Y. MicroRNA-411 and Its 5′-isomiR have distinct targets and functions and are differentially regulated in the vasculature under ischemia. Mol. Ther. 28, 157–170 (2020).
Guduric-Fuchs, J. et al. Deep sequencing reveals predominant expression of miR-21 amongst the small non-coding RNAs in retinal microvascular endothelial cells. J. Cell Biochem. 113, 2098–2111 (2012).
Newman, M. A., Mani, V. & Hammond, S. M. Deep sequencing of microRNA precursors reveals extensive 3′ end modification. RNA 17, 1795–1803 (2011).
Voellenkle, C. et al. Deep-sequencing of endothelial cells exposed to hypoxia reveals the complexity of known and novel microRNAs. RNA 18, 472–484 (2012).
Shen, J. et al. EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2. Nature 497, 383–387 (2013).
Stellos, K. et al. Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation. Nat. Med. 22, 1140–1150 (2016).
Lauressergues, D. et al. Primary transcripts of microRNAs encode regulatory peptides. Nature 520, 90–93 (2015).
Niu, L. et al. A micropeptide encoded by lncRNA MIR155HG suppresses autoimmune inflammation via modulating antigen presentation. Sci. Adv. 6, eaaz2059 (2020).
Prel, A., Dozier, C., Combier, J. P., Plaza, S. & Besson, A. Evidence that regulation of Pri-miRNA/miRNA expression is not a general rule of miPEPs function in humans. Int. J. Mol. Sci. 22, 3432 (2021).
Razooky, B. S., Obermayer, B., O’May, J. B. & Tarakhovsky, A. Viral infection identifies micropeptides differentially regulated in smORF-containing lncRNAs. Genes 8, 206 (2017).
Makarewich, C. A. & Olson, E. N. Mining for micropeptides. Trends Cell Biol. 27, 685–696 (2017).
Brunet, M. A. et al. OpenProt 2021: deeper functional annotation of the coding potential of eukaryotic genomes. Nucleic Acids Res. 49, D380–D388 (2021).
van Heesch, S. et al. The translational landscape of the human heart. Cell 178, 242–260.e29 (2019).
Doll, S. et al. Region and cell-type resolved quantitative proteomic map of the human heart. Nat. Commun. 8, 1469 (2017).
Kang, M. et al. Identification of miPEP133 as a novel tumor-suppressor microprotein encoded by miR-34a pri-miRNA. Mol. Cancer 19, 143 (2020).
Yan, Y. et al. The cardiac translational landscape reveals that micropeptides are new players involved in cardiomyocyte hypertrophy. Mol. Ther. 29, 2253–2267 (2021).
Roundtree, I. A., Evans, M. E., Pan, T. & He, C. Dynamic RNA modifications in gene expression regulation. Cell 169, 1187–1200 (2017).
Chamorro-Jorganes, A. et al. METTL3 regulates angiogenesis by modulating let-7e-5p and miRNA-18a-5p expression in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 41, e325–e337 (2021).
Alarcon, C. R. et al. HNRNPA2B1 is a mediator of m(6)A-dependent nuclear RNA processing events. Cell 162, 1299–1308 (2015).
Alarcon, C. R., Lee, H., Goodarzi, H., Halberg, N. & Tavazoie, S. F. N6-methyladenosine marks primary microRNAs for processing. Nature 519, 482–485 (2015).
Seok, H. et al. Position-specific oxidation of miR-1 encodes cardiac hypertrophy. Nature 584, 279–285 (2020).
Paul, D. et al. A-to-I editing in human miRNAs is enriched in seed sequence, influenced by sequence contexts and significantly hypoedited in glioblastoma multiforme. Sci. Rep. 7, 2466 (2017).
van der Kwast, R. et al. Adenosine-to-inosine editing of vasoactive micrornas alters their targetome and function in ischemia. Mol. Ther. Nucleic Acids 21, 932–953 (2020).
Kawahara, Y. et al. Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science 315, 1137–1140 (2007).
van der Kwast, R. et al. Adenosine-to-inosine editing of microRNA-487b alters target gene selection after ischemia and promotes neovascularization. Circ. Res. 122, 444–456 (2018).
Lee, R. C., Feinbaum, R. L. & Ambros, V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843–854 (1993).
La Rocca, G. et al. In vivo, Argonaute-bound microRNAs exist predominantly in a reservoir of low molecular weight complexes not associated with mRNA. Proc. Natl Acad. Sci. USA 112, 767–772 (2015).
Gregory, R. I., Chendrimada, T. P., Cooch, N. & Shiekhattar, R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 123, 631–640 (2005).
Hock, J. et al. Proteomic and functional analysis of Argonaute-containing mRNA-protein complexes in human cells. EMBO Rep. 8, 1052–1060 (2007).
Saxton, R. A. & Sabatini, D. M. mTOR signaling in growth, metabolism, and disease. Cell 168, 960–976 (2017).
Olejniczak, S. H., La Rocca, G., Gruber, J. J. & Thompson, C. B. Long-lived microRNA-Argonaute complexes in quiescent cells can be activated to regulate mitogenic responses. Proc. Natl Acad. Sci. USA 110, 157–162 (2013).
Androsavich, J. R., Chau, B. N., Bhat, B., Linsley, P. S. & Walter, N. G. Disease-linked microRNA-21 exhibits drastically reduced mRNA binding and silencing activity in healthy mouse liver. RNA 18, 1510–1526 (2012).
Zhang, K. et al. A novel class of microRNA-recognition elements that function only within open reading frames. Nat. Struct. Mol. Biol. 25, 1019–1027 (2018).
Schirle, N. T., Sheu-Gruttadauria, J. & MacRae, I. J. Structural basis for microRNA targeting. Science 346, 608–613 (2014).
Sheu-Gruttadauria, J. & MacRae, I. J. Phase transitions in the assembly and function of human miRISC. Cell 173, 946–957 (2018).
Burroughs, A. M. et al. Deep-sequencing of human Argonaute-associated small RNAs provides insight into miRNA sorting and reveals Argonaute association with RNA fragments of diverse origin. RNA Biol. 8, 158–177 (2011).
Weinmann, L. et al. Importin 8 is a gene silencing factor that targets argonaute proteins to distinct mRNAs. Cell 136, 496–507 (2009).
Flores, O., Kennedy, E. M., Skalsky, R. L. & Cullen, B. R. Differential RISC association of endogenous human microRNAs predicts their inhibitory potential. Nucleic Acids Res. 42, 4629–4639 (2014).
Janas, M. M. et al. Alternative RISC assembly: binding and repression of microRNA-mRNA duplexes by human Ago proteins. RNA 18, 2041–2055 (2012).
Kundu, P., Fabian, M. R., Sonenberg, N., Bhattacharyya, S. N. & Filipowicz, W. HuR protein attenuates miRNA-mediated repression by promoting miRISC dissociation from the target RNA. Nucleic Acids Res. 40, 5088–5100 (2012).
Mukherjee, K. et al. Reversible HuR-microRNA binding controls extracellular export of miR-122 and augments stress response. EMBO Rep. 17, 1184–1203 (2016).
Poria, D. K., Guha, A., Nandi, I. & Ray, P. S. RNA-binding protein HuR sequesters microRNA-21 to prevent translation repression of proinflammatory tumor suppressor gene programmed cell death 4. Oncogene 35, 1703–1715 (2016).
Liu, S. et al. HuR (human antigen R) regulates the contraction of vascular smooth muscle and maintains blood pressure. Arterioscler. Thromb. Vasc. Biol. 40, 943–957 (2020).
Green, L. C. et al. Human antigen R as a therapeutic target in pathological cardiac hypertrophy. JCI Insight 4, e121541 (2019).
Hu, H. et al. HuR regulates phospholamban expression in isoproterenol-induced cardiac remodelling. Cardiovasc. Res. 116, 944–955 (2020).
Villarroya-Beltri, C. et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat. Commun. 4, 2980 (2013).
Santangelo, L. et al. The RNA-binding protein SYNCRIP is a component of the hepatocyte exosomal machinery controlling microRNA sorting. Cell Rep. 17, 799–808 (2016).
Eiring, A. M. et al. miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell 140, 652–665 (2010).
Belter, A. et al. Mature miRNAs form secondary structure, which suggests their function beyond RISC. PLoS ONE 9, e113848 (2014).
Yang, D. et al. MicroRNA biophysically modulates cardiac action potential by direct binding to ion channel. Circulation 143, 1597–1613 (2021).
Hentze, M. W., Castello, A., Schwarzl, T. & Preiss, T. A brave new world of RNA-binding proteins. Nat. Rev. Mol. Cell Biol. 19, 327–341 (2018).
Vion, A. C. et al. Autophagy is required for endothelial cell alignment and atheroprotection under physiological blood flow. Proc. Natl Acad. Sci. USA 114, E8675–E8684 (2017).
Zhao, Y. et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129, 303–317 (2007).
Pegan, S. et al. Cytoplasmic domain structures of Kir2.1 and Kir3.1 show sites for modulating gating and rectification. Nat. Neurosci. 8, 279–287 (2005).
Hasegawa, K. et al. A novel KCNQ1 missense mutation identified in a patient with juvenile-onset atrial fibrillation causes constitutively open IKs channels. Heart Rhythm 11, 67–75 (2014).
Hattori, T. et al. A novel gain-of-function KCNJ2 mutation associated with short-QT syndrome impairs inward rectification of Kir2.1 currents. Cardiovasc. Res. 93, 666–673 (2012).
Yekta, S., Shih, I. H. & Bartel, D. P. MicroRNA-directed cleavage of HOXB8 mRNA. Science 304, 594–596 (2004).
Davis, E. et al. RNAi-mediated allelic trans-interaction at the imprinted Rtl1/Peg11 locus. Curr. Biol. 15, 743–749 (2005).
Hansen, T. B. et al. Natural RNA circles function as efficient microRNA sponges. Nature 495, 384–388 (2013).
Helwak, A., Kudla, G., Dudnakova, T. & Tollervey, D. Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 153, 654–665 (2013).
Chi, S. W., Zang, J. B., Mele, A. & Darnell, R. B. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 460, 479–486 (2009).
Chen, J. et al. mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts. Circ. Res. 112, 1557–1566 (2013).
Chamorro-Jorganes, A. et al. VEGF-induced expression of miR-17-92 cluster in endothelial cells is mediated by ERK/ELK1 activation and regulates angiogenesis. Circ. Res. 118, 38–47 (2016).
Doebele, C. et al. Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells. Blood 115, 4944–4950 (2010).
Khraiwesh, B. et al. Transcriptional control of gene expression by microRNAs. Cell 140, 111–122 (2010).
Mathiyalagan, P. et al. The primary microRNA-208b interacts with polycomb-group protein, Ezh2, to regulate gene expression in the heart. Nucleic Acids Res. 42, 790–803 (2014).
Kim, D. H., Saetrom, P., Snove, O. Jr. & Rossi, J. J. MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc. Natl Acad. Sci. USA 105, 16230–16235 (2008).
Singh, I. et al. MiCEE is a ncRNA-protein complex that mediates epigenetic silencing and nucleolar organization. Nat. Genet. 50, 990–1001 (2018).
Khan, A. W. et al. MeCP2 interacts with chromosomal microRNAs in brain. Epigenetics 12, 1028–1037 (2017).
Khan, A. W. et al. NET silencing by let-7i in postural tachycardia syndrome. JCI Insight 2, e90183 (2017).
Farina, F. M. et al. miR-128-3p is a novel regulator of vascular smooth muscle cell phenotypic switch and vascular diseases. Circ. Res. 126, e120–e135 (2020).
Li, H. et al. Identification of ncRNA-mediated functions of nucleus-localized miR-320 in cardiomyocytes. Mol. Ther. Nucleic Acids 19, 132–143 (2020).
Li, H. et al. Nuclear miR-320 mediates diabetes-induced cardiac dysfunction by activating transcription of fatty acid metabolic genes to cause lipotoxicity in the heart. Circ. Res. 125, 1106–1120 (2019).
Fan, J. et al. Nuclear miR-665 aggravates heart failure via suppressing phosphatase and tensin homolog transcription. Sci. China Life Sci. 63, 724–736 (2020).
Di Mauro, V., Crasto, S., Colombo, F. S., Di Pasquale, E. & Catalucci, D. Wnt signalling mediates miR-133a nuclear re-localization for the transcriptional control of Dnmt3b in cardiac cells. Sci. Rep. 9, 9320 (2019).
Zhang, Y. et al. Cellular microRNAs up-regulate transcription via interaction with promoter TATA-box motifs. RNA 20, 1878–1889 (2014).
Huang, V. et al. Ago1 Interacts with RNA polymerase II and binds to the promoters of actively transcribed genes in human cancer cells. PLoS Genet. 9, e1003821 (2013).
Guo, H. et al. Nuclear miR-30b-5p suppresses TFEB-mediated lysosomal biogenesis and autophagy. Cell Death Differ. 28, 320–336 (2021).
Xiao, M. et al. MicroRNAs activate gene transcription epigenetically as an enhancer trigger. RNA Biol. 14, 1326–1334 (2017).
Suzuki, H. I., Young, R. A. & Sharp, P. A. Super-enhancer-mediated RNA processing revealed by integrative MicroRNA network analysis. Cell 168, 1000–1014.e15 (2017).
Sabari, B. R. et al. Coactivator condensation at super-enhancers links phase separation and gene control. Science 361, eaar3958 (2018).
Klein, I. A. et al. Partitioning of cancer therapeutics in nuclear condensates. Science 368, 1386–1392 (2020).
Jie, M. et al. Subcellular localization of miRNAs and implications in cellular homeostasis. Genes 12, 856 (2021).
Elguindy, M. M. & Mendell, J. T. NORAD-induced Pumilio phase separation is required for genome stability. Nature 595, 303–308 (2021).
Robb, G. B., Brown, K. M., Khurana, J. & Rana, T. M. Specific and potent RNAi in the nucleus of human cells. Nat. Struct. Mol. Biol. 12, 133–137 (2005).
Nishi, K., Nishi, A., Nagasawa, T. & Ui-Tei, K. Human TNRC6A is an Argonaute-navigator protein for microRNA-mediated gene silencing in the nucleus. RNA 19, 17–35 (2013).
Gagnon, K. T., Li, L., Chu, Y., Janowski, B. A. & Corey, D. R. RNAi factors are present and active in human cell nuclei. Cell Rep. 6, 211–221 (2014).
Pitchiaya, S., Heinicke, L. A., Park, J. I., Cameron, E. L. & Walter, N. G. Resolving subcellular miRNA trafficking and turnover at single-molecule resolution. Cell Rep. 19, 630–642 (2017).
Ohrt, T. et al. Fluorescence correlation spectroscopy and fluorescence cross-correlation spectroscopy reveal the cytoplasmic origination of loaded nuclear RISC in vivo in human cells. Nucleic Acids Res. 36, 6439–6449 (2008).
Sarshad, A. A. et al. Argonaute-miRNA complexes silence target mRNAs in the nucleus of mammalian stem cells. Mol. Cell 71, 1040–1050 (2018).
Cremer, S. et al. Hematopoietic deficiency of the long noncoding RNA MALAT1 promotes atherosclerosis and plaque inflammation. Circulation 139, 1320–1334 (2019).
Leucci, E. et al. microRNA-9 targets the long non-coding RNA MALAT1 for degradation in the nucleus. Sci. Rep. 3, 2535 (2013).
Wang, D. et al. Nuclear miR-122 directly regulates the biogenesis of cell survival oncomiR miR-21 at the posttranscriptional level. Nucleic Acids Res. 46, 2012–2029 (2018).
Tang, R. et al. Mouse miRNA-709 directly regulates miRNA-15a/16-1 biogenesis at the posttranscriptional level in the nucleus: evidence for a microRNA hierarchy system. Cell Res. 22, 504–515 (2012).
Ro, S. et al. The mitochondrial genome encodes abundant small noncoding RNAs. Cell Res. 23, 759–774 (2013).
Mercer, T. R. et al. The human mitochondrial transcriptome. Cell 146, 645–658 (2011).
Zhang, X. et al. MicroRNA directly enhances mitochondrial translation during muscle differentiation. Cell 158, 607–619 (2014).
Das, S. et al. Nuclear miRNA regulates the mitochondrial genome in the heart. Circ. Res. 110, 1596–1603 (2012).
Das, S. et al. miR-181c regulates the mitochondrial genome, bioenergetics, and propensity for heart failure in vivo. PLoS ONE 9, e96820 (2014).
Li, H. et al. MicroRNA-21 lowers blood pressure in spontaneous hypertensive rats by upregulating mitochondrial translation. Circulation 134, 734–751 (2016).
Li, H. et al. The different roles of miRNA-92a-2-5p and let-7b-5p in mitochondrial translation in db/db Mice. Mol. Ther. Nucleic Acids 17, 424–435 (2019).
Jagannathan, R. et al. Translational regulation of the mitochondrial genome following redistribution of mitochondrial microRNA in the diabetic heart. Circ. Cardiovasc. Genet. 8, 785–802 (2015).
Shepherd, D. L. et al. Exploring the mitochondrial microRNA import pathway through polynucleotide phosphorylase (PNPase). J. Mol. Cell Cardiol. 110, 15–25 (2017).
Zampetaki, A. et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ. Res. 107, 810–817 (2010).
Santovito, D. et al. Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control. J. Clin. Endocrinol. Metab. 99, E1681–E1685 (2014).
D’Alessandra, Y. et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur. Heart J. 31, 2765–2773 (2010).
Kaur, A. et al. Systematic review of microRNA biomarkers in acute coronary syndrome and stable coronary artery disease. Cardiovasc. Res. 116, 1113–1124 (2020).
Sahoo, S. et al. Therapeutic and diagnostic translation of extracellular vesicles in cardiovascular diseases: roadmap to the clinic. Circulation 143, 1426–1449 (2021).
Kesidou, D. et al. Extracellular vesicle miRNAs in the promotion of cardiac neovascularisation. Front. Physiol. 11, 579892 (2020).
Mori, M. A., Ludwig, R. G., Garcia-Martin, R., Brandao, B. B. & Kahn, C. R. Extracellular miRNAs: from biomarkers to mediators of physiology and disease. Cell Metab. 30, 656–673 (2019).
Santovito, D. & Weber, C. Zooming in on microRNAs for refining cardiovascular risk prediction in secondary prevention. Eur. Heart J. 38, 524–528 (2017).
Poller, W. et al. Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives. Eur. Heart J. 39, 2704–2716 (2018).
Jaen, R. I. et al. Innate immune receptors, key actors in cardiovascular diseases. JACC Basic Transl Sci. 5, 735–749 (2020).
Fabbri, M. et al. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc. Natl Acad. Sci. USA 109, E2110–E2116 (2012).
Lehmann, S. M. et al. An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat. Neurosci. 15, 827–835 (2012).
Feng, Y. et al. Extracellular microRNAs induce potent innate immune responses via TLR7/MyD88-dependent mechanisms. J. Immunol. 199, 2106–2117 (2017).
Pluta, L., Yousefi, B., Damania, B. & Khan, A. A. Endosomal TLR-8 senses microRNA-1294 resulting in the production of NFkB dependent cytokines. Front. Immunol. 10, 2860 (2019).
Park, C. K. et al. Extracellular microRNAs activate nociceptor neurons to elicit pain via TLR7 and TRPA1. Neuron 82, 47–54 (2014).
Han, Q. et al. miRNA-711 binds and activates TRPA1 extracellularly to evoke acute and chronic pruritus. Neuron 99, 449–463 (2018).
Mohanta, S. K. et al. Neuroimmune cardiovascular interfaces regulate atherosclerosis. Nature 605, 152–159 (2022).
Villain, G. et al. miR-126-5p promotes retinal endothelial cell survival through SetD5 regulation in neurons. Development 145, dev156232 (2018).
Rayner, K. J. et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328, 1570–1573 (2010).
Rayner, K. J. et al. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J. Clin. Invest. 121, 2921–2931 (2011).
Goedeke, L. et al. Long-term therapeutic silencing of miR-33 increases circulating triglyceride levels and hepatic lipid accumulation in mice. EMBO Mol. Med. 6, 1133–1141 (2014).
Goedeke, L. et al. A regulatory role for microRNA 33* in controlling lipid metabolism gene expression. Mol. Cell Biol. 33, 2339–2352 (2013).
Su, Y. et al. MicroRNA-181a-5p and microRNA-181a-3p cooperatively restrict vascular inflammation and atherosclerosis. Cell Death Dis. 10, 365 (2019).
Urbich, C. et al. MicroRNA-27a/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A. Blood 119, 1607–1616 (2012).
Xie, W. et al. MicroRNA-27 prevents atherosclerosis by suppressing lipoprotein lipase-induced lipid accumulation and inflammatory response in apolipoprotein E knockout mice. PLoS ONE 11, e0157085 (2016).
Chinchilla, A. et al. MicroRNA profiling during mouse ventricular maturation: a role for miR-27 modulating Mef2c expression. Cardiovasc. Res. 89, 98–108 (2011).
Tian, C., Hu, G., Gao, L., Hackfort, B. T. & Zucker, I. H. Extracellular vesicular MicroRNA-27a* contributes to cardiac hypertrophy in chronic heart failure. J. Mol. Cell Cardiol. 143, 120–131 (2020).
Chen, B., Yang, Y., Wu, J., Song, J. & Lu, J. microRNA-17-5p downregulation inhibits autophagy and myocardial remodelling after myocardial infarction by targeting STAT3. Autoimmunity 55, 43–51 (2022).
Li, W., Deng, P., Wang, J., Li, Z. & Zhang, H. MiR-17 knockdown promotes vascular smooth muscle cell phenotypic modulation through upregulated interferon regulator factor 9 expression. Am. J. Hypertens. 33, 1119–1126 (2020).
Li, S. H. et al. miR-17 targets tissue inhibitor of metalloproteinase 1 and 2 to modulate cardiac matrix remodeling. FASEB J. 27, 4254–4265 (2013).
Shi, J. et al. miR-17-3p contributes to exercise-induced cardiac growth and protects against myocardial ischemia-reperfusion injury. Theranostics 7, 664–676 (2017).
Liu, Z. et al. Serum extracellular vesicles promote proliferation of H9C2 cardiomyocytes by increasing miR-17-3p. Biochem. Biophys. Res. Commun. 499, 441–446 (2018).
Iwasaki, S. et al. Hsc70/Hsp90 chaperone machinery mediates ATP-dependent RISC loading of small RNA duplexes. Mol. Cell 39, 292–299 (2010).
Schirle, N. T. & MacRae, I. J. The crystal structure of human Argonaute2. Science 336, 1037–1040 (2012).
Pfaff, J. et al. Structural features of Argonaute-GW182 protein interactions. Proc. Natl Acad. Sci. USA 110, E3770–E3779 (2013).
Wahle, E. & Winkler, G. S. RNA decay machines: deadenylation by the Ccr4-not and Pan2-Pan3 complexes. Biochim. Biophys. Acta 1829, 561–570 (2013).
Braun, J. E., Huntzinger, E., Fauser, M. & Izaurralde, E. GW182 proteins directly recruit cytoplasmic deadenylase complexes to miRNA targets. Mol. Cell 44, 120–133 (2011).
Fabian, M. R. et al. miRNA-mediated deadenylation is orchestrated by GW182 through two conserved motifs that interact with CCR4-NOT. Nat. Struct. Mol. Biol. 18, 1211–1217 (2011).
Mathys, H. et al. Structural and biochemical insights to the role of the CCR4-NOT complex and DDX6 ATPase in microRNA repression. Mol. Cell 54, 751–765 (2014).
Mugridge, J. S., Ziemniak, M., Jemielity, J. & Gross, J. D. Structural basis of mRNA-cap recognition by Dcp1-Dcp2. Nat. Struct. Mol. Biol. 23, 987–994 (2016).
Kamenska, A. et al. The DDX6-4E-T interaction mediates translational repression and P-body assembly. Nucleic Acids Res. 44, 6318–6334 (2016).
Cougot, N., Babajko, S. & Seraphin, B. Cytoplasmic foci are sites of mRNA decay in human cells. J. Cell Biol. 165, 31–40 (2004).
Eulalio, A., Behm-Ansmant, I., Schweizer, D. & Izaurralde, E. P-body formation is a consequence, not the cause, of RNA-mediated gene silencing. Mol. Cell Biol. 27, 3970–3981 (2007).
Leung, A. K., Calabrese, J. M. & Sharp, P. A. Quantitative analysis of Argonaute protein reveals microRNA-dependent localization to stress granules. Proc. Natl Acad. Sci. USA 103, 18125–18130 (2006).
Sripada, L. et al. hsa-miR-4485 regulates mitochondrial functions and inhibits the tumorigenicity of breast cancer cells. J. Mol. Med. 95, 641–651 (2017).
Turchinovich, A., Weiz, L., Langheinz, A. & Burwinkel, B. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 39, 7223–7233 (2011).
Wang, K., Zhang, S., Weber, J., Baxter, D. & Galas, D. J. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res. 38, 7248–7259 (2010).
Vickers, K. C., Palmisano, B. T., Shoucri, B. M., Shamburek, R. D. & Remaley, A. T. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 13, 423–433 (2011).
Garcia-Martin, R. et al. MicroRNA sequence codes for small extracellular vesicle release and cellular retention. Nature 601, 446–451 (2022).
Lu, P. et al. MEX3C interacts with adaptor-related protein complex 2 and involves in miR-451a exosomal sorting. PLoS ONE 12, e0185992 (2017).
Acknowledgements
The work of the authors is supported by the Deutsche Forschungsgemeinschaft (DFG; nos. 403584255 — TRR 267-A2 and SFB1123-A1/A10 to C.W.) and by the European Research Council (ERC; AdG 692511 to C.W.). C.W. is a Van de Laar professor of atherosclerosis.
Author information
Authors and Affiliations
Contributions
Both authors contributed substantially to all aspects of the article.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Reviews Cardiology thanks Constanza Emanueli, Thomas Thum and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Related links
miRbase: http://www.mirbase.org/
mirtronDB: http://mirtrondb.cp.utfpr.edu.br/
OpenProt: https://openprot.org/
Rights and permissions
About this article
Cite this article
Santovito, D., Weber, C. Non-canonical features of microRNAs: paradigms emerging from cardiovascular disease. Nat Rev Cardiol 19, 620–638 (2022). https://doi.org/10.1038/s41569-022-00680-2
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41569-022-00680-2
This article is cited by
-
Non-coding RNAs as therapeutic targets and biomarkers in ischaemic heart disease
Nature Reviews Cardiology (2024)
-
RNA-binding proteins in cardiovascular biology and disease: the beat goes on
Nature Reviews Cardiology (2024)
-
Ssc-mir-221-3p regulates melanin production in Xiang pigs melanocytes by targeting the TYRP1 gene
BMC Genomics (2023)
-
RNA modifications in cardiovascular health and disease
Nature Reviews Cardiology (2023)
-
Oral pathogen aggravates atherosclerosis by inducing smooth muscle cell apoptosis and repressing macrophage efferocytosis
International Journal of Oral Science (2023)